VNA
VTVT icon

Valley National Advisers’s vTv Therapeutics VTVT Stock Holding History

Valley National Advisers’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.9K Buy
+980
New +$34K ﹤0.01% 445

Other funds holding VTVT

CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Valley National Advisers's VTVT Position: Q2 2026 in Review

Valley National Advisers opened a new position in vTv Therapeutics (VTVT) in Q2 2026: 980 shares worth $36.9K. The stake represents ﹤0.01% of the portfolio and ranks #445 among its holdings.

6 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Valley National Advisers held 980 shares of vTv Therapeutics worth $36.9K as of Q2 2026.
  • vTv Therapeutics was a new Valley National Advisers position in Q2 2026.
  • vTv Therapeutics made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #445 holding.
  • 6 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.